A well-known marker of endothelial dysfunction is reduced production of vasodilators (e.g., nitric oxide and prostaglandins) in lieu of vasoconstrictive factors (e.g., thromboxane A2 and endothelin 1) [2]. This evidence concerns the gene EDN1 and endothelial dysfunction.